Sponsor hub
Insel Gruppe AG, University Hospital Bern clinical trial failures
Review 27 stopped clinical trials from Insel Gruppe AG, University Hospital Bern, including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 1 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OPERATIONAL
- 14
- OTHER/UNKNOWN
- 12
- EFFICACY/FUTILITY
- 1
Notable sponsors
- Insel Gruppe AG, University Hospital Bern
- 27
Related phases
- Phase I
- 8
- Phase II
- 7
- Phase IV
- 7
- Phase III
- 2
- Unknown
- 2
Crawlable stopped-trial records
Open ExploreShowing up to 27 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Phase IV Pain trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OPERATIONAL.
Recruitment difficulties
Phase I Lymphoma trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OPERATIONAL.
low accrual
Phase IV Postoperative Nausea and Vomiting trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OPERATIONAL.
Low recruiting rate
Phase II Fertility Disorders trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OTHER/UNKNOWN.
The planned study medication was no longer available in Switzerland
Phase I Advanced Urothelial Carcinoma trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OTHER/UNKNOWN.
IMP security Issues reported by Sponsor
Early Phase I Type 1 Diabetes trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OPERATIONAL.
Prioritization of other projects
Phase I Healthy trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OTHER/UNKNOWN.
Formulations could never be successfully produced
Phase I AML, Adult trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OPERATIONAL.
Insufficient recruitment
Phase IV Procedural Anxiety trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OTHER/UNKNOWN.
Sponsor left the hospital
Phase III SARS-CoV Infection trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OPERATIONAL.
Insufficient rate of patient accrual and newly available scientific evidence
Phase II Vulvar Lichen Sclerosus trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OPERATIONAL.
Recruitment problems
Phase IV Menopause trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OPERATIONAL.
massive recruitment problems became apparent because of the strict inclusion criteria of our study.
Phase II SARS-CoV-2 Infection trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OPERATIONAL.
1.) Not possible to recruit the planned number of patients during the planned study period; 2.) "Dexamethason" was included in the standard of care for the study population during the course of the study and inclusion criteria could no longer be met.
Phase II Muscle-invasive Bladder Cancer trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OPERATIONAL.
low accrual
Phase IV Retinal Detachment trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OPERATIONAL.
Persisting recruitment difficulties
Unknown Essential Hypertension trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OTHER/UNKNOWN.
PI moved away from Bern; lack of personnel in Bern to conduct the study within a reasonable time frame.
Phase III Thrombosis Portal Vein trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OPERATIONAL.
lack of funding
Phase I Meningitis trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OPERATIONAL.
Insufficient patient recruitment
Unknown Hypopituitarism trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase I AML trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OTHER/UNKNOWN.
IMP will not be further developed
Phase I AML trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OTHER/UNKNOWN.
IMP will not be further developed
Phase II Lymphoma, Large B-Cell, Diffuse trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OTHER/UNKNOWN.
Celgene withdrew the support for this study (Durvalumab cannot be provided)
Phase II Liver Resection trial by Insel Gruppe AG, University Hospital Bern. Stop reason: EFFICACY/FUTILITY.
Interim analysis revealed that no statistical difference will be identified after inclusion of the patient cohort as foreseen in the sample size calculation
Phase II Aortic Valve Disease trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OTHER/UNKNOWN.
not enough patients
Phase I Gastroenteropancreatic Neuroendocrine Tumors trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OTHER/UNKNOWN.
Superiority of one imaging method
Phase IV Urinary Tract Infections trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OTHER/UNKNOWN.
New power calculation (reduction of necessary patient number)
Phase IV Chronic Pelvic Pain Syndrome trial by Insel Gruppe AG, University Hospital Bern. Stop reason: OPERATIONAL.
Recruitment problems